By Michael Erman and Kamal Choudhury NEW YORK, Oct 29 (Reuters) – Merck said on Thursday it plans to raise its revenue forecast from new products over the next decade, buoyed by recent clinical trial
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Subscribers: Please add the following to the Reuters Daybook for today, Thursday, October 29: (HEALTH-MATERNITY-IOWA/KENNEDY)…
Oct 29 (Reuters) - Microport Scientific Corp: * SHANGHAI MICROPORT ENDOVASCULAR MEDTECH NINE-MONTH REVENUE UP…
Oct 29 (Reuters) - General Motors will pay $220 million to settle allegations that it…
Oct 29 (Reuters) - Global Dominion Access, S.A. : * 9-MONTH EBITDA €94.6 MILLION *…
By Essi Lehto and Elviira Luoma HELSINKI, Oct 29 (Reuters) - Finnish police said on…
Oct 29 (Reuters) - Banca Monte dei Paschi di Siena CEO Luigi Lovaglio says in…